Inhibitory Effect of Lotus Leaf-Enriched Flavonoid Extract on the Growth of HT-29 Colon Cancer Cells through the Expression of PI3K-Related Molecules

Li, Chong; Zhou, Zhanming; Long, Xingyao; Pan, Yanni; Wang, Rui; Chen, Xiufeng; Zhao, Xin

doi:https://doi.org/10.1155/2022/6770135

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 6770135 | https://doi.org/10.1155/2022/6770135

Inhibitory Effect of Lotus Leaf-Enriched Flavonoid Extract on the Growth of HT-29 Colon Cancer Cells through the Expression of PI3K-Related Molecules

Chong Li,^1,2,3Zhanming Zhou,⁴Xingyao Long,^1,2,3Yanni Pan,^1,2,3Rui Wang,^1,2,3Xiufeng Chen ,⁵and Xin Zhao¹

Academic Editor: Ali Imran

Received31 Dec 2021

Accepted15 Apr 2022

Published09 May 2022

Abstract

Objectives. Lotus leaf is rich in flavonoids, and this study is aimed at examining the inhibitory effect of lotus leaf-enriched flavonoid extract (LLEFE) on HT-29 colon cancer cells through phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) expression regulation. Methods. Lotus leaves were extracted by ethanol and purified using FL-3 macroporous resin to create the LLEFE. HT-29 colon cancer cells were tested using various methods: their proliferation was observed by 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay, their survival status was observed by fluorescence staining, their oxidative stress level was observed by biochemical kits, and their mRNA expression was determined by quantitative polymerase chain reaction (qPCR) assay. Additionally, the composition of the flavonoids in lotus leaf was determined by HPLC. Results. The results showed that the proliferation of NCM460 normal human colon cells was not affected by 0–500 μg/mL LLEFE but the proliferation of HT-29 human colon cancer cells decreased. LLEFE increased the LDH level in an HT-29 colon cancer cell culture medium; also increased the superoxide dismutase (SOD), catalase (CAT) activities, and glutathione (GSH) level in HT-29 cells; and decreased the malondialdehyde (MDA) level. Further experimental results showed that LLEFE upregulated the expression of SOD1, CAT, and GSH mRNA and downregulated the expression of PI3K, Akt, and mammalian target of rapamycin (mTOR) in HT-29 cells. The high-performance liquid chromatography (HPLC) results showed that kaempferin, hyperoside, astragaloside, phloridzin, and quercetin were the main chemical constituents of lotus leaf. Conclusion. Lotus leaves contain functional flavonoids that inhibit the proliferation of HT-29 colon cancer cells and regulate the expression of PI3K/Akt through five important chemicals.

1. Introduction

Lotus (Nelumbo spp.) is a perennial herbaceous aquatic plant from the Nelumbonaceae family. Its leaves are often dried and then brewed as a tea [1]. In traditional Chinese medicine (TCM), lotus leaf is used to clear away heat and toxins, cool the blood, and stop bleeding [2]. In traditional Chinese medicine, lotus leaf is used for relieving heat, invigorating the spleen and stomach, regulating defecation, and others [3]. Lotus leaf tea assists in a variety of health functions [4]. Studies have shown that flavonoids and alkaloids, which are active substances, are found in the highest concentration in lotus leaves. Lotus leaf-enriched flavonoid extract (LLEFE) decreases blood lipids, relieves cardiovascular diseases, and possesses antiallergy, antiaging, antibacterial, and antioxidant properties [5–9]. Lotus leaf can be obtained from a wide range of plants, which makes it convenient to use as a TCM.

Colon cancer is a malignant gastrointestinal cancer. Chronic colitis and colon polyps may become carcinogenic [10]. Therefore, in addition to drug treatments to improve the quality of life and prolong the life of patients with colon cancer, prevention of symptoms, such as chronic colitis and colonic polyps, can reduce colon cancer. Studies have shown that plant flavonoids have preventive and interventional effects on colitis and colon polyps. Flavonoids can prevent and fight cancer mainly through three avenues: antifree radical, direct inhibition of cancer cell growth, and anticarcinogenic factors [11]. Carcinogenic contributors such as physicochemical factors lead to the enrichment of free radicals in the body, cause lipid peroxidation, destroy cellular DNA, and cause cancer. Flavonoids are free radical quenchers and antioxidants that can effectively prevent cell damage caused by lipid peroxidation and play an anticancer role [12].

In particular, flavonoids from natural plants can be added to functional foods that will then reduce the incidence of inflammation and cancer [11, 12]. Some studies have shown that a LLEFE can inhibit the proliferation of prostate cancer cells [13]. Animal research indicates that other plant flavonoids can directly inhibit liver and cervical cancer [14, 15]. In vitro experiments showed that different plant flavonoids exerted satisfactory specific inhibitory effects on different cancer cells. Tangerine peel inhibited the metastasis of mouse colon cancer, the growth of S180 cells, the growth and metastasis of Lewis lung cancer, and the growth of mouse melanoma B16. The combination of tangerine peel and hesperidin resulted in high inhibition of mouse WEHI3B (JCS) cells. It was also shown that hesperidin inhibits lung cancer [16]. The mechanism used by lotus leaf flavonoids may be similar and may act against cancer.

The expression of the PI3K/Akt signaling pathway is abnormally activated in some cancers. The two most widely discovered mechanisms of PI3K/Akt activation in human cancer are triggered by receptor tyrosine kinase (RTK) and somatic mutations in specific elements of the signaling pathway [17]. Stimulation and promotion of the PI3K pathway may negatively impact cancer treatment, and therefore, inhibition of PI3K may inhibit cancer development [18]. Abnormal stimulation of the PI3K/Akt pathway is associated with tumor growth and angiogenesis. The loss of PTEN function, which is usually seen in human tumors, leads to the stimulation of the PI3K/Akt pathway [19]. The key expression of the PI3K/Akt pathway results in clinically targeted therapeutic effects, including those that affect PI3K, Akt, and mTOR [20]. In this study, we verified that HT-29 colon cancer cells were inhibited by LLEFE via regulation of the PI3K/Akt signaling pathway in vitro. We also elucidated the relationship between the active components of LLEFE and the regulation of the PI3K/Akt signaling pathway.

2. Materials and Methods

2.1. LLEFE Extraction

To prepare the herb, 250 g of dried lotus leaves (Anhui Shoufeng Biotechnology Co. Ltd., Haozhou, Anhui, China) were weighed, crushed, and added to a 5 L beaker. Then, 4 L of 70% ethanol was added according to a 1 : 20 ratio of lotus leaves to ethanol (). The beaker was placed in a water bath pot at 60°C for 3 h. The beaker was then removed and cooled. The mixture was pumped and filtered to obtain the lotus leaf-enriched flavonoid extract (LLEFE). The LLEFE crude extract was poured into a glass column containing FL-3 macroporous resin and filtered (Jiangsu Hecheng New Material Co. Ltd., Nanjing, Jiangsu, China). The filtrate from the first pass through the resin was discarded. After all of the extract was passed through the column, the glass column was eluted with 70% ethanol until the resin became colorless. The elution solution underwent rotary evaporation to remove the ethanol, and finally, the LLEFE was obtained [21].

2.2. Cancer Cell Culture

HT-29 human colon cancer cells and NCM460 normal human colon cells (Cyagen Biotechnology Co. Ltd., Taicang, Jiangsu, China) were used in this experiment. To prepare the culture medium, 10% fetal bovine serum (FBS) () and 1% penicillin-streptomycin () were added to RPMI-1640 medium (Solarbio Life Sciences, Beijing, China). HT-29 and NCM460 cells were grown in this medium at 37°C under 5% CO₂. The medium was changed every two days. The experimental group was divided into control and LLEFE groups. The control group cells were not treated with LLEFE, but the LLEFE groups were treated with 0–500 μg/mL LLEFE.

2.3. Cell Proliferation Detection by MTT Assay

For the MTT assay, 180 μL of cells were seeded into 96-well plates. The cells were incubated at 37°C under a 5% CO₂ atmosphere for 24 h. After the cells adhered to the plate walls, an additional 20 μL of different concentrations of LLEFE solution was added to each well of the treatment group and the control group was treated with no LLEFE. After incubation for 48 h, the medium was discarded and 200 μL of MTT reagent (the MTT reagent was dissolved in RPMI-1640 medium at a final concentration of 5 mg/mL; Solarbio Life Sciences, Beijing, China) was added to each well. After incubation for 4 h, the supernatant was discarded and 200 μL of dimethyl sulfoxide was then added to each well. The OD value of each well was measured at 490 nm, and the inhibition rate of cell proliferation was calculated. [22].

2.4. Determination of Lactate Dehydrogenase (LDH), Superoxide Dismutase (SOD), Malondialdehyde (MDA), Glutathione (GSH), and Catalase (CAT) Levels in HT-29 Colon Cancer Cells

After the cells were treated according to the abovementioned methods, HT-29 human colon cancer cells were treated with LLEFE for 48 h. The medium was analyzed to determine the LDH levels as per the kit’s instructions. Then, the cells were lysed by ultrasonication in an ice-water bath (vibrated for 3–5 s, repeated three times at 4 s intervals). The SOD, CAT activities, MDA, and GSH levels in the cells were also determined according to the instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China).

2.5. Observation of HT-29 Colon Cancer Cell Survival

To measure cell survival, cells were seeded in 6-well plates, cultured for 48 h, and then treated with LLEFE. HT-29 cell survival was observed under an inverted fluorescence microscope with a calcein-acetoxymethyl (AM)/propidium iodide (PI) double-staining kit. The living cells were labeled with green fluorescence, and the dead cells were labeled with red fluorescence (Olympus IX71 microscope, Tokyo, Japan).

2.6. qPCR Experiment

The total RNA was extracted using a kit (BaiMaiKe Technologies, Beijing, China), and the RNA concentration and purity were determined by a microspectrophotometer. Reverse transcription of RNA into cDNA was performed using a RevertAid First-Strand cDNA synthesis kit. Hieff™ qPCR SYBR® Green Master Mix (High Rox Plus) (Yeasen Technologies, Shanghai, China) and a real-time PCR system (StepOnePlus, Thermo Scientific, Bellefonte, PA, USA) were used to measure the target gene expression levels (Table 1). PCR was performed under the following conditions: denaturation was performed at 95°C for 3 min and then 60 cycles at 95°C for 15 s each, annealing was performed at 5°C for 30 s, denaturation was performed at 95°C for 30 s, and annealing was performed with 55 cycles for 35 s each. β-Actin was used for target gene expression, and the relative strength of expression was computed using the method [22].

2.7. HPLC Assay

HPLC was used to determine the composition of the compounds in the LLEFE. The chromatographic conditions were as follows (UltiMate 3000 HPLC system, Thermo Fisher Scientific). A C18 chromatographic column (, 2.6 μm, Thermo Fisher Scientific) was used with mobile phase A of 100% methanol and mobile phase B of 0.5% acetic acid. The flow rate was 0.5 mL/min, and the column temperature was 30°C. A UV-Vis detector was used with a detection wavelength of 285 nm, and the injection volume was 10 μL. The amount of each LLEFE component was calculated using an external standard method: , where (mg/g) represents the component content, (mg/mL) denotes the mass concentration of the standard, denotes the peak area of the sample, denotes the peak area of the standard, and (1.0 mg/mL) denotes the concentration of the sample stock solution.

2.8. Statistical Analysis

SPSS 17.0 and GraphPad-Prism 7 software were used to analyze the data. Three parallel experiments were carried out throughout the study, and the experimental results were then averaged, and the standard deviation was calculated and expressed as the deviation (SD). One-way ANOVA and -test were used to analyze whether there was a statistical difference at the level of .

3. Results

3.1. Effect of LLEFE on Cell Proliferation

Figure 1 shows that 0–500 μg/mL of LLEFE exhibited only minor effects on the growth and proliferation of NCM460 normal human colon cells. At the same concentration, LLEFE inhibited the growth and proliferation of HT-29 human colon cancer cells and the inhibition rate increased with the increase in LLEFE concentration. At 125, 250, and 500 μg/mL concentrations, LLEFE inhibited the proliferation of HT-29 human colon cancer cells by 19.98%, 55.85%, and 83.51%, respectively (Table 2). Based on the abovementioned experimental results, 125, 250, and 500 μg/mL concentrations of LLEFE were used thereafter.

(a)

(b)

3.2. LDH Levels in HT-29 Colon Cancer Cell Culture Medium

As shown in Figure 2, the LDH level in the cell culture fluid of the control group was the lowest (125.62 U/L). As the concentration of LLEFE increased, the LDH level in the cell culture fluid also increased. The LDH levels in the culture medium of HT-29 colon cancer cells were 278.36, 418.76, and 655.87 U/L after treatment with LLEFE at 125, 250, and 500 μg/mL, respectively.

3.3. SOD, MDA, GSH, and CAT Levels in HT-29 Colon Cancer Cells

As shown in Table 3, after 125, 250, and 500 μg/mL of LLEFE treatment, the SOD and CAT enzymatic activities and GSH levels in all three treatment groups were significantly increased (), whereas the MDA level was significantly decreased ().

3.4. HT-29 Colon Cancer Cell Survival Status

As shown in Figure 3, the HT-29 cell survival status was observed under an inverted fluorescence microscope. Control HT-29 cells were numerous, full, polygonal, and abundantly cytoplasmic, with numerous intense cells visible by fluorescent staining. HT-29 cells treated with LLEFE appeared shrunken and damaged, in decreased numbers, or dead. An increase in the concentration of LLEFE decreased the number of HT-29 cells and aggravated cell injury and death. These observations indicated that LLEFE inhibited the growth of HT-29 cancer cells.

3.5. mRNA Expression of HT-29 Colon Cancer Cells

As shown in Figure 4, the control HT-29 cells showed the weakest SOD1, CAT, and GSH mRNA expression and the strongest PI3K, Akt, and mTOR mRNA expression. LLEFE was able to significantly () upregulate SOD1, CAT, and GSH and significantly () downregulate PI3K, Akt, and mTOR expression in HT-29 colon cancer cells. Moreover, with increasing LLEFE concentration (500 μg/mL), there was stronger expression of SOD1 (4.739-fold of the control), CAT (3.262-fold of the control), and GSH (3.687-fold of the control), while there was weaker expression of PI3K (0.176-fold of the control), Akt (0.218-fold of the control), and mTOR (0.333-fold of the control).

3.6. Analysis of LLEFE Composition

As shown in Figure 5, the main chemical components in LLEFE were kaempferin, hyperoside, syringin, phlorizin, and quercetin. The amount of kaempferol was the highest at 77.62 mg/g, and the amounts of hyperoside, syringin, phlorizin, and quercetin were 35.12, 10.06, 0.31, and 0.12 mg/g, respectively.

(a)

(b)

4. Discussion

There was no effect or a reduced toxic effect of the active substance on normal somatic cells [23]. We were able to explore the mechanism of LLEFE’s induction of cancer cell apoptosis. Under normal physiological conditions, the LDH content in body fluids is low and intracellular LDH is released only after cell membrane rupture [24]. Therefore, HT-29 cancer cells were damaged by LLEFE. A large amount of LDH was released into the medium after the membrane of HT-29 cells was broken and HT-29 cancer cells were more damaged with increasing LLEFE concentration.

Studies have shown that fairly high ROS levels exist in cancer cells, which often aid in cancer cell growth and proliferation [25]. As the main endogenous antioxidant in the body, SOD scavenges excessive ROS, decreases the mitochondrial damage in normal cells, and maintains body homeostasis [26]. GSH and CAT are also important antioxidants in the body and inhibit normal cellular damage caused by ROS [25]. MDA is a product of oxidative damage that can reveal the extent of cell damage [27]. It was thus suggested that the oxidative stress response in HT-29 cancer cells under LLEFE was inhibited, which inhibits the normal growth and proliferation of cancer cells.

Some studies have shown that the PI3K/Akt signaling pathway plays an important role in colorectal carcinogenesis by inducing tumor cell growth, differentiation, and vascularization, thus serving as a novel therapeutic target for colorectal cancer intervention [28]. Both PI3K and mTOR inhibitors suppress cancer cells under laboratory conditions, and some of these less toxic inhibitors have been validated in clinical trials and thus have the potential to act as promising new anticancer agents [29]. mTOR is a key kinase downstream of PI3K/Akt that plays a role in regulating cancer cell growth, proliferation, survival, and even metastasis [30]. PI3K, Akt, and mTOR expression can inhibit cancer cell proapoptotic factors in the body and activate anticancer cell apoptosis factors to promote cancer initiation and progression. PI3K-Akt-mTOR inhibits the activity of proapoptotic factors by phosphorylation while activating antiapoptotic factors. Studies have shown that the PI3K-Akt-mTOR signaling pathway plays a role in cancer cell proliferation. Deregulation of the PI3K-Akt-mTOR pathway may cause cancer recurrence and metastasis [31].

Additional studies have found that PI3K/Akt pathway activation promotes colorectal cancer cell proliferation and PI3KCA mutations are a common cause of this pathway activation. Clinical and experimental studies have shown that PI3KCA mutations may play an important role in the development of microsatellite instability (MSI) colorectal cancer and regulation of the PI3K/Akt pathway can effectively inhibit PI3KCA mutations [32]. A colorectal cancer study found that the PI3K/Akt signaling pathway induced angiogenic gene expression, promoted the formation of colon cancer blood vessels, and promoted tumor vascularization and metastasis [33]. More importantly, PI3K transmits mitotic signals to P70S6K1 through Akt and mTOR, which upregulates the translation of major cell cycle proteins, such as cyclin, and accelerates the cell cycle [34]. After PI3K activation promotes cell cycle progression, leading to the occurrence and development of colorectal cancer, inhibition of PI3K activity can lead to cell G1 arrest, inhibiting cell cycle progression and cancer cells [35].

Under normal physiological conditions, the body has the ability to withstand the stimulation of ROS. A low concentration of ROS in vivo is necessary for normal physiological metabolism. A large amount of ROS can stimulate an increase in antioxidant enzymes such as SOD and CAT that protect normal cells. When the body becomes cancerous, cancer cells are at a higher level of oxidative stress compared with normal cells and this oxidative stress causes normal cell damage. Oxidative stress also promotes the ROS level to stimulate and activate PI3K/Akt, thereby enhancing the proliferative ability of cancer cells [36]. In the present study, LLEFE effectively inhibited PI3K, Akt, and mTOR expression in the PI3K/Akt pathway and the process by which oxidative stress activates this pathway. This inhibited HT-29 cancer cell growth and proliferation.

Hydrogen peroxide (H₂O₂) is closely related to the level of LDH after cell injury, and the level intensity of H₂O₂ is highly consistent with the level of LDH. Studies have shown that lotus leaf flavonoids have a strong protective effect on normal cells. Under the same conditions, tea polyphenols and vitamin C have a strong inhibitory effect on the oxidative damage of normal cells, especially by adjusting the level of hydrogen peroxide. H₂O₂ can activate the expression of P13K/Akt [37], and it was also shown that wortmannin or LY294002, an inhibitor of P13K, promoted H₂O₂-regulated apoptosis. Therefore, the regulation of P13K/Akt expression can regulate the effect of H₂O₂ on cell injury [38].

LLEFE mainly contains five compounds (kaempferin, hyperoside, syringin, phlorizin, and quercetin) that are all flavonoids with promising antioxidant effects [39–43]. Hyperoside, phlorizin, and quercetin exert some confirmed anticancer effects [39–41]. Animal experiments showed that hyperoside can exert antioxidant effects through a PI3K/Akt regulation mechanism [42]. Another study confirmed that phlorizin can regulate the IRS2/PI3K/Akt pathway and reduce the accumulation of mitochondrial reactive oxygen species (ROS) to protect tissues [43]. Syringin can stimulate PI3K/Akt to regulate the body to maintain normalcy and avoid diseases including osteoporosis [44]. Quercetin can regulate PI3K/Akt-induced apoptosis of HL-60 cells and directly inhibit human promyelocytic leukemia cells [45]. The present study also confirmed that LLEFE containing these compounds inhibits the growth and proliferation of HT-29 colon cancer cells in vitro. LLEFE may effectively regulate the PI3K/Akt pathway, inhibit PI3K/Akt expression by the effective chemical compounds that it contains, control the level of oxidative stress, and inhibit colon cancer proliferation.

5. Conclusions

This study found that LLEFE inhibits HT-29 cancer cells without affecting normal cells, which may indicate anticancer specificity. At the same time, studies have shown that LLEFE regulates the expression and related expression of PI3K/Akt, which may be the key to its role. Further compositional analysis revealed that LLEFE contains five important flavonoid compounds and the combined effects of these compounds regulated the expression of the PI3K/Akt to inhibit HT-29 colon cancer cells. The effect and mechanism of LLEFE on colon cancer have only been preliminarily verified by in vitro experiments herein. Because it is a natural product and its action mechanism is complex, we only observed its effect on PI3K/Akt expression in this study and further study is required to elucidate its effect on additional pathways and its comprehensive effects. This study preliminarily verified the effects of LLEFE and provides a theoretical basis for further effective development of LLEFE as a new natural drug material.

Data Availability

The datasets generated for this study are available upon request to the corresponding author.

Conflicts of Interest

All authors declare that they have no competing interests.

Authors’ Contributions

Chong Li and Zhanming Zhou are mainly responsible for the content of the experiment and manuscript writing; Xingyao Long, Yanni Pan, and Rui Wang are mainly involved in data analysis research; Xiufeng Chen and Xin Zhao oversaw the research and reviewed the final manuscript. Chong Li and Zhanming Zhou contributed equally to this work.

Acknowledgments

This research was supported by the Chongqing University Innovation Research Group Project (CXQTP20033), TCM Science and Technology Guidance Project of Chongqing Health and Family Planning Commission (ZY201703016), Children’s Research Institute of School Planning and Construction Development Center for Chongqing University of Education (CRIKT202001), and Project of Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJZD-K201901602), China.

References

L. H. Ye, X. X. He, M. Z. Yan, and Q. Chang, “Identification of in vivo components in rats after oral administration of lotus leaf flavonoids using ultra fast liquid chromatography with tandem mass spectrometry,” Analytical Methods, vol. 6, no. 15, pp. 6088–6094, 2014.
View at: Publisher Site | Google Scholar
L. Liao, J. Chen, L. Liu, and A. Xiao, “Protective effects of flavonoids from lotus leaf against exercise-induced oxidant stress in muscle of mice,” Journal of the Brazilian Chemical Society, vol. 29, no. 3, pp. 587–593, 2018.
View at: Google Scholar
L. Zhang, “Protective effects of flavonoids from lotus leaf against exercise-induced oxidant stress in muscle of mice,” Applied Mechanics and Materials, vol. 448-453, pp. 1089–1092, 2013.
View at: Publisher Site | Google Scholar
Q. X. Chen and J. Liu, “Study on processing technology of lotus leaf tea and optimization of extraction technology of lotus leaf tea by orthogonal test,” Shaanxi Journal of Traditional Chinese Medicine, vol. 40, no. 9, pp. 1300–1303, 2019.
View at: Google Scholar
J. J. Wang, T. Long, X. Cao et al., “The influence of flavonoids extracted from lotus on the triglyceride metabolism of HepG2 cells incubated in oleic acid,” Journal of Applied Physiology, vol. 26, no. 12, pp. 1626–1630, 2010.
View at: Google Scholar
X. Tan, P. Tang, and L. Liu, “Molecular structure-affinity relationship of flavonoids in lotus leaf (Nelumbo nucifera Gaertn.) on binding to human serum albumin and bovine serum albumin by spectroscopic method,” Molecules, vol. 22, no. 7, p. 1036, 2017.
View at: Publisher Site | Google Scholar
D. Su, N. Li, M. Chen et al., “Effects of in vitro digestion on the composition of flavonoids and antioxidant activities of the lotus leaf at different growth stages,” International Journal of Food Science & Technology, vol. 53, no. 7, pp. 1631–1639, 2018.
View at: Publisher Site | Google Scholar
H. Wu, “Study on antioxidant capacity of flavonoids from lotus leaf,” Anhui Agricultural Science Bulletin, vol. 22, no. 16, pp. 15–17, 2016.
View at: Google Scholar
G. Song, P. Zhao, Z. Yan, J. Chen, and S. Mo, “The application of alkaloids and flavonoids in the treatment of obesity and diabetes,” China Health Care & Nutrition, vol. 27, no. 34, pp. 76-77, 2017.
View at: Google Scholar
P. Kuppusamy, M. M. Yusoff, G. P. Maniam, S. J. A. Ichwan, I. Soundharrajan, and N. Govindan, “Nutraceuticals as potential therapeutic agents for colon cancer: a review,” Acta Pharmaceutica Sinica B, vol. 4, no. 3, pp. 173–181, 2014.
View at: Publisher Site | Google Scholar
S. Aranganathan, J. P. Selvam, and N. E. Nalini, “Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study,” Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1385–1392, 2010.
View at: Publisher Site | Google Scholar
S. H. Sharma, J. S. Kumar, D. R. Chellappan, and S. Nagarajan, “Molecular chemoprevention by morin - a plant flavonoid that targets nuclear factor kappa B in experimental colon cancer,” Biomedicine & Pharmacotherapy, vol. 100, no. 1, pp. 367–373, 2018.
View at: Publisher Site | Google Scholar
Z. Liu, B. Liao, C. Xia, S. Cheng, Y. Zhang, and J. Liu, “Total flavonoids of lotus leaves inhibits human-derived prostate cancer cell proliferation,” China Medicine, vol. 13, no. 12, pp. 1865–1869, 2018.
View at: Google Scholar
S. T. Chien, M. D. Shi, Y. C. Lee, C. C. te, and Y. W. Shih, “Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells,” Cancer Cell International, vol. 15, no. 1, p. 15, 2015.
View at: Publisher Site | Google Scholar
J. H. Kim, J. W. Kang, M. S. Kim et al., “The apoptotic effects of the flavonoid N101-2 in human cervical cancer cells,” Toxicology In Vitro, vol. 26, no. 1, pp. 67–73, 2012.
View at: Google Scholar
R. Huang, Y. Zhang, S. Shen et al., “Antioxidant and pancreatic lipase inhibitory effects of flavonoids from different citrus peel extracts: An in vitro study,” Food Science, vol. 326, no. 1, p. 126785, 2020.
View at: Publisher Site | Google Scholar
J. Y. Kim, E. A. Welsh, B. Fang et al., “Phosphoproteomics reveals MAPK inhibitors enhance MET- and EGFR-driven AKT signaling inKRAS-mutant lung cancer,” Molecular Cancer Research, vol. 14, no. 10, pp. 1019–1029, 2016.
View at: Publisher Site | Google Scholar
H. Ebi, R. B. Corcoran, A. Singh et al., “Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers,” Journal of Clinical Investigations, vol. 121, no. 11, pp. 4311–4321, 2011.
View at: Publisher Site | Google Scholar
H. P. Kourea, V. Zolota, and C. D. Scopa, “Targeted pathways in breast cancer: molecular and protein markers guiding therapeutic decisions,” Current Molecular Pharmacology, vol. 7, no. 1, pp. 4–21, 2014.
View at: Publisher Site | Google Scholar
Y. L. Chen, P. Y. Law, and H. H. Loh, “Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy,” Current Medicinal Chemistry-Anti-Cancer Agents, vol. 5, no. 6, pp. 575–589, 2005.
View at: Publisher Site | Google Scholar
C. Li, J. He, Y. Yang et al., “White tip silver needle (slightly fermented white tea) flavonoids help prevent aging via antioxidative and anti-inflammatory effects,” Drug Design, Development and Therapy, vol. 15, pp. 1441–1457, 2021.
View at: Publisher Site | Google Scholar
Y. Qian, J. L. Song, P. Sun et al., “Lactobacillus casei strain Shirota enhances the in vitro antiproliferative effect of geniposide in human oral squamous carcinoma HSC-3 cells,” Molecules, vol. 23, no. 5, p. 1069, 2018.
View at: Publisher Site | Google Scholar
C. Raaymakers, E. Verbrugghe, B. Stijlemans, A. Martel, F. Pasmans, and K. Roelants, “The anuran skin peptide bradykinin mediates its own absorption across epithelial barriers of the digestive tract,” Peptides, vol. 103, pp. 84–89, 2018.
View at: Publisher Site | Google Scholar
Z. Tang, C. Wu, X. Guo, Q. Yu, J. He, and H. Zhang, “Si-MLK4 regulates ROS/MAPKs signaling pathway inducing apoptosis of renal cell car-cinoma cells,” Journal of Modern Oncology, vol. 28, no. 19, pp. 3311–3315, 2020.
View at: Google Scholar
W. Fu, D. Sui, X. Yu, D. Gou, Y. Zhou, and H. Xu, “Protective effects of ginsenoside Rg2 against H2O2-induced injury and apoptosis in H9c2 cells,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 11, pp. 19938–19947, 2015.
View at: Google Scholar
A. T. Ibrahim, “Negative impacts of ultraviolet-a radiation on antioxidant and oxidative stress biomarkers of African catfish Clarias gariepinus,” Photochemical and Photobiological Sciences, vol. 14, no. 7, pp. 1337–1345, 2015.
View at: Publisher Site | Google Scholar
J. Lykkesfeldt, “Malondialdehyde as biomarker of oxidative damage to lipids caused by smoking,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 50–58, 2007.
View at: Publisher Site | Google Scholar
H. Niu and P. He, “Rapid metabolic recovery following vigorous exercise in burrow-dwelling larval sea lampreys (Petromyzon marinus),” Chinese General Practice, vol. 10, no. 23, pp. 2019–2021, 2007.
View at: Google Scholar
M. Feng, H. Xu, H. He et al., “Study on inducing apoptosis of gastric cancer cells of total triterpenoids from Chaenomeles speciosa by regulating miR-10a and PI3K/Akt/mTOR/p70S6K signaling pathways,” Journal of Chinese Medicinal Materials, vol. 42, no. 12, pp. 2929–2935, 2019.
View at: Google Scholar
X. Zhu and H. Chen, “Targeting PI3K-AKT-mTOR by wortmannin inhibits cell growth in human skin squamous cell carcinoma,” Chinese Journal of Dermatovenereology, vol. 34, no. 1, pp. 21–25, 2020.
View at: Google Scholar
C. H. E. N. Chen, Y. I. N. Yuan-yuan, and W. U. Xia-fang, “Advance in researches on role of MAPK and PI3K/AKT pathways in ROS-induced activation of nuclear factor erythroid 2-related factor 2,” Chinese Journal of Public Health, vol. 32, no. 6, pp. 870–873, 2016.
View at: Google Scholar
C. Lucchetti, F. Rizzolio, M. Castronovo, and G. Toffoli, “Research highlights. PI3K/AKT/mTOR inhibitors would require PI3KCA-mutation analysis,” Pharmacogenomics, vol. 12, no. 10, p. 1382, 2011.
View at: Publisher Site | Google Scholar
X. Zhai, Y. Li, P. Liang et al., “PI3K/AKT/Afadin signaling pathway contributes to pathological vascularization in glioblastomas,” Oncology Letters, vol. 15, no. 2, pp. 1893–1899, 2018.
View at: Publisher Site | Google Scholar
E. O. de Souza, V. Tricoli, C. Bueno Junior et al., “The acute effects of strength, endurance and concurrent exercises on the Akt/mTOR/p70S6K1 and AMPK signaling pathway responses in rat skeletal muscle,” Brazilian Journal of Medical and Biological Research, vol. 46, no. 4, pp. 343–347, 2013.
View at: Publisher Site | Google Scholar
N. Gao, D. C. Flynn, Z. Zhang et al., “G1cell cycle progression and the expression of G1cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells,” AJP Cell Physiology, vol. 287, no. 2, pp. 281–291, 2004.
View at: Publisher Site | Google Scholar
S. Papaiahgari, Q. Zhang, S. R. Kleeberger, H. Y. Cho, and S. P. Reddy, “Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells,” Antioxidants and Redox Signaling, vol. 8, no. 1-2, pp. 43–52, 2006.
View at: Publisher Site | Google Scholar
X. Chen and J. Qi, “Flavonoids and alkaloids in lotus leaves,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 21, no. 18, pp. 211–214, 2015.
View at: Google Scholar
E. H. Walker, M. E. Pacold, O. Perisic et al., “Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine,” Molecular Cell, vol. 6, no. 4, pp. 909–919, 2000.
View at: Publisher Site | Google Scholar
Y. H. Chang, Y. Xu, L. Yu, and X.Y. Li, “Determination of kaempferitrin in tagetes erecta L. by HPLC,” Northwest Pharmaceutical Journal, vol. 19, no. 4, pp. 162-163, 2004.
View at: Google Scholar
H. Wang, J. Cheng, H. Wang, M. Wang, J. Zhao, and Z. Wu, “Protective effect of apple phlorizin on hydrogen peroxide-induced cell damage in HepG2 cells,” Journal of Food Biochemistry, vol. 43, no. 12, article e13052, 2019.
View at: Publisher Site | Google Scholar
Z. Wang, W. Tang, and F. Lin, “Effects of hyperoside on apoptosis and antioxidative capacity of cervical cancer Hela cells,” Chinese Journal of Coal Industry Medicine, vol. 22, no. 4, pp. 402–407, 2019.
View at: Google Scholar
J. Han, J. L. Xuan, H. R. Hu, and Z. W. Chen, “Protective effect against myocardial ischemia reperfusion injuries induced by hyperoside preconditioning and its relationship with PI3K/Akt signaling pathway in rats,” China Journal of Chinese Materia Medica, vol. 40, no. 1, pp. 118–123, 2015.
View at: Google Scholar
D. Li, Y. Yang, L. Sun et al., “Effect of young apple Malus domestica Borkh. cv. Red Fuji polyphenols on alleviating insulin resistance,” Food Bioscience, vol. 36, no. 7, p. 100637, 2020.
View at: Publisher Site | Google Scholar
J. J. Liu, Z. Z. Zhang, Q. Guo, Y. Dong, Q. Zhao, and X. Ma, “Syringin prevents bone loss in ovariectomized mice _via_ TRAF6 mediated inhibition of NF- κB and stimulation of PI3K/AKT,” Phytomedicine, vol. 42, pp. 43–50, 2018.
View at: Publisher Site | Google Scholar
Z. Yuan, C. Long, T. Junming, L. Qihuan, Z. Youshun, and Z. Chan, “Quercetin-induced apoptosis of HL-60 cells by reducing PI3K/Akt,” Molecular Biology Reports, vol. 39, no. 7, pp. 7785–7793, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Chong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

439

Downloads

782

Citations